Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
3R01FD002543-03S1
Application #
7498358
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Program Officer
Lewis, Debra Y
Project Start
2004-09-01
Project End
2008-02-28
Budget Start
2006-09-01
Budget End
2008-02-28
Support Year
3
Fiscal Year
2007
Total Cost
Indirect Cost

  Institution

Name
Retina Foundation of the Southwest
Department
Type
DUNS #
127069466
City
Dallas
State
TX
Country
United States
Zip Code
75231

  Publications

Hoffman, Dennis R; Hughbanks-Wheaton, Dianna K; Spencer, Rand et al. (2015) Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial. Invest Ophthalmol Vis Sci 56:6646-53
Birch, David G; Locke, Kirsten G; Felius, Joost et al. (2015) Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa. Ophthalmology 122:833-9
Hoffman, Dennis R; Hughbanks-Wheaton, Dianna K; Pearson, N Shirlene et al. (2014) Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial. JAMA Ophthalmol 132:866-73
Hughbanks-Wheaton, Dianna K; Birch, David G; Fish, Gary E et al. (2014) Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial. Invest Ophthalmol Vis Sci 55:4958-66
Birch, David G; Locke, Kirsten G; Wen, Yuquan et al. (2013) Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 131:1143-50